After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

Rather than go to battle, Walmsley opened the door and listened to the investor’s demands as she spun off part of the company ...

GSK has revealed updated results from its phase ... published in the New England Journal of Medicine, bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... patterns in large data sets to determine the optimal medicine combinations while enabling researchers to investigate ...

GSK also pleaded guilty to the accusation that it breached the requirement that a medicine must not be promoted before the grant of its marketing authorization, but the panel reached a different ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow refreshing and invigorating. After all, that oh-so familiar routine of phone calls, online ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 ...